This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
These new findings, which are part of an ongoing Phase II study , will be presented at the 2024 American Society of Clinical Oncology (ASCO) meeting and the European Hematology Association ( Abstract #6503 ). They explained that cyclophosphamide “counteracts” graft vs. host disease (GVHD) , a serious sideeffect of transplantation.
The deal includes Karuna’s lead asset KarXT (xanomeline-trospium), a potential first-in-class treatment for schizophrenia. It has demonstrated improvements in cognition and is not associated with common sideeffects of currently approved treatments like weight gain.
. “I am very excited about the agreement with Bristol Myers Squibb.With the BrainTransporter technology, BioArctic has the capability to lead in the design and development of the next generation of treatments for various brain disorders, offering the potential of faster uptake, improved efficacy, less sideeffects and lower doses for the benefit (..)
One leading proponent of the approach – South San Francisco’s Nkarta – has just reported new results from an early-stage trial of one of its CAR-NK therapies that will likely add to the enthusiasm for the field. Those will get underway in 2024.
To mark World Kidney Day 2024, Dr Marshall Fordyce, CEO of Vera Therapeutics, spoke with EPR about the challenges of treating kidney diseases, specifically IgAN, a condition caused by dysfunctional B cells. Individuals who receive corticosteroids may experience limited efficacy, alongside significant sideeffects.
To mark World Kidney Day 2024, Dr Marshall Fordyce, CEO of Vera Therapeutics, spoke with EPR about the challenges of treating kidney diseases, specifically IgAN, a condition caused by dysfunctional B cells. Individuals who receive corticosteroids may experience limited efficacy, alongside significant sideeffects.
We took a look at these drugs’ impact on the medtech sector for our forthcoming report, Medtech Trends to Watch in 2024 , and found a more nuanced picture. Device-based treatments for comorbidities associated with obesity will also see an impact. You can register for the webinar here.
It is a challenging proposition, however, as delivery of the therapeutic gene sequences to cells can be difficult and raises the risk of insertion mutations that can lead to sideeffects, including cancer.
New data presented at Psych Congress 2024 has shown that the olanzapine long-acting injectable (LAI) TEV-‘749 / mdc-TJK demonstrated “significant improvement” in social functioning and quality of life in adults with schizophrenia. Teva is leading clinical development, the regulatory process and commercialisation of UZEDY and TEV-‘749.
From there, doctors can discuss symptoms and explore testing options that can lead to a faster diagnosis. Additionally, delivering content about screenings to patients when they’re already in a healthcare state of mind can lead to better health outcomes.
Belgium-headquartered ANeuroTech is participating in a Series B round, which will raise up to $150m to power the pivotal programme of its lead candidate ANT01 for use as an adjunctive treatment for major depressive disorder (MDD). The company aims to run an interim analysis of the trial by mid-2024 at the very latest.
month mPFS with Keytruda plus chemo, with fewer sideeffects. A key readout for BMS will be a front-line phase 2 study of its combination in NSCLC due to read out in 2024, but its unclear if that could support approval so Immutep could be able to maintain a lead in this type of cancer.
But commercializing an oncology product in 2024 means identifying and linking to an authentic shortfall in the lived experience of a patient with cancer, not just a perceived gap in the market. Serious” sideeffects? Until recently, commercialization of an oncology product was similar to any other pharmaceutical launch.
Toby Katcher SVP, Video Investment, Dept Lead CMI Media Group tkatcher@cmimediagroup.com Building trust equity is crucial, but it’s difficult and full of challenges that might compromise a brand’s credibility and authenticity. Keeping messages consistent across different platforms is another difficulty that can lead to fragmented experiences.
A treatment’s impact on utilization of other healthcare services: The effects of a treatment can lead to changes in the utilization of other healthcare products and services, such as hospitalizations, surgeries, or use of other drugs.
1 As they can be highly targeted in their action, they could become the treatment of choice for clinicians and patients due to the reduced risk of sideeffects. Because ADCs offer a good way to specifically deliver an effective treatment to tumour systems, this could be an improvement on the systemic impact of chemotherapy.
3 By actively listening to providers and addressing their objections with tailored solutions, sales professionals can cultivate strong relationships that lead to success in this competitive field. They may have valid concerns about the product’s cost, potential sideeffects, or its suitability for their patients.
By identifying biological targets for new drugs and finding potential compounds that interact effectively with the target, new compounds can be developed that enhance effectiveness and reduce sideeffects. However, it can lead to overutilization of services and may not incentivize quality or outcomes.
However, the EMA expressed concerns around overall efficacy and, coupled with a concern raised over possible sideeffects presenting as brain abnormalities suggestive of swelling or bleeding on the brain, led the EMA to the view, following a re-examination process, that it would not recommend the approval of Aduhelm.
BROADWAY and BOOKLYN will generate data in 2024, with PREVAIL set to read to in 2026, and if the results are positive will be followed by filings in the US, Europe, China and Japan. So why will obicetrapib avoid the pitfalls of its predecessors?
stuart.long@infobionic.com SHYAM SAKHRANI Senior Director, Global Offering Lead, Patient Engagement and Support, IQVIA Digital health tools and technologies are gaining acceptance and are being more widely adopted by consumers. Educational materials for patients, both print out and online, have been used to address common sideeffects.
billion during 2020-2024. AI can lead to faster research, combining and extracting data into usable formats, making clinical trials more efficient and saving time. The Emergence of the Pharmacovigilance Market Medicines and vaccines often have unwanted and severe sideeffects. from 2023 to 2030. billion by 2027.
Ideally, insights from MSL activities lead to better evidence and more successful development programs and patient outcomes. For example, imagine if a new product in development carries with it transformational efficacy and an uncommon sideeffect that needs to be carefully managed by a specialty other than the treating specialty.
And with therapy underway, many of these programs help boost adherence¹ by addressing common barriers to compliance, like missed doses, sideeffects, and unreliable information about the drug and disease.² They promote access to therapy by helping eligible patients afford their medications.
Technological advancements, shifting market dynamics, and updated regulations are leading to significant changes within the pharmaceutical industry. Preventing Misuse: Strict regulations are required to stop the improper use and abuse of drugs, especially those that have strong sideeffects or the potential to become addictive.
I was thankful and blessed to connect with one of the leading researchers on my subtype. At my age, he was like, “You had such a great response to chemo that you have a higher chance of dealing with major issues and potential fatality from radiation sideeffects in twenty years versus the cancer coming back.” He’s a great guy.
Although effective, this approach often results in significant sideeffects, including increased susceptibility to viral reactivation, infections, and, in some cases, a heightened risk of cancer due to reduced immune surveillance. 2024; 11(3). cited 2024 Oct]. References Fox RJ, Heinz Wiendl, Wolf C, et al.
The demand came amid concerns that the drug causes a slew of sideeffects such as nausea, diarrhea, and liver issues. In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov. What is drug dose optimisation?
GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. This additional feedback also leads to improvements to the NMT, to ensure it achieves continuous high-quality translations. This includes assessing content for MT viability, and pilot testing.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content